Menu
GeneBe

rs1249463

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002180.3(IGHMBP2):c.57T>C(p.Leu19=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.814 in 1,550,292 control chromosomes in the GnomAD database, including 517,889 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.76 ( 44837 hom., cov: 34)
Exomes 𝑓: 0.82 ( 473052 hom. )

Consequence

IGHMBP2
NM_002180.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 0.0150
Variant links:
Genes affected
IGHMBP2 (HGNC:5542): (immunoglobulin mu DNA binding protein 2) This gene encodes a helicase superfamily member that binds a specific DNA sequence from the immunoglobulin mu chain switch region. Mutations in this gene lead to spinal muscle atrophy with respiratory distress type 1. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 11-68904009-T-C is Benign according to our data. Variant chr11-68904009-T-C is described in ClinVar as [Benign]. Clinvar id is 258575.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-68904009-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.015 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.837 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
IGHMBP2NM_002180.3 linkuse as main transcriptc.57T>C p.Leu19= synonymous_variant 1/15 ENST00000255078.8
IGHMBP2XM_047426881.1 linkuse as main transcriptc.57T>C p.Leu19= synonymous_variant 1/15
IGHMBP2XM_017017671.3 linkuse as main transcriptc.57T>C p.Leu19= synonymous_variant 1/12
IGHMBP2XM_005273976.3 linkuse as main transcriptc.57T>C p.Leu19= synonymous_variant 1/9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
IGHMBP2ENST00000255078.8 linkuse as main transcriptc.57T>C p.Leu19= synonymous_variant 1/151 NM_002180.3 P1

Frequencies

GnomAD3 genomes
AF:
0.759
AC:
115447
AN:
152028
Hom.:
44809
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.627
Gnomad AMI
AF:
0.910
Gnomad AMR
AF:
0.826
Gnomad ASJ
AF:
0.796
Gnomad EAS
AF:
0.489
Gnomad SAS
AF:
0.731
Gnomad FIN
AF:
0.758
Gnomad MID
AF:
0.803
Gnomad NFE
AF:
0.843
Gnomad OTH
AF:
0.788
GnomAD3 exomes
AF:
0.769
AC:
118247
AN:
153684
Hom.:
46316
AF XY:
0.772
AC XY:
62926
AN XY:
81544
show subpopulations
Gnomad AFR exome
AF:
0.618
Gnomad AMR exome
AF:
0.799
Gnomad ASJ exome
AF:
0.797
Gnomad EAS exome
AF:
0.472
Gnomad SAS exome
AF:
0.743
Gnomad FIN exome
AF:
0.757
Gnomad NFE exome
AF:
0.844
Gnomad OTH exome
AF:
0.795
GnomAD4 exome
AF:
0.820
AC:
1146146
AN:
1398142
Hom.:
473052
Cov.:
59
AF XY:
0.818
AC XY:
564363
AN XY:
689706
show subpopulations
Gnomad4 AFR exome
AF:
0.625
Gnomad4 AMR exome
AF:
0.798
Gnomad4 ASJ exome
AF:
0.798
Gnomad4 EAS exome
AF:
0.533
Gnomad4 SAS exome
AF:
0.746
Gnomad4 FIN exome
AF:
0.757
Gnomad4 NFE exome
AF:
0.846
Gnomad4 OTH exome
AF:
0.788
GnomAD4 genome
AF:
0.759
AC:
115526
AN:
152150
Hom.:
44837
Cov.:
34
AF XY:
0.758
AC XY:
56397
AN XY:
74388
show subpopulations
Gnomad4 AFR
AF:
0.628
Gnomad4 AMR
AF:
0.826
Gnomad4 ASJ
AF:
0.796
Gnomad4 EAS
AF:
0.488
Gnomad4 SAS
AF:
0.730
Gnomad4 FIN
AF:
0.758
Gnomad4 NFE
AF:
0.843
Gnomad4 OTH
AF:
0.786
Alfa
AF:
0.818
Hom.:
30016
Bravo
AF:
0.758
Asia WGS
AF:
0.622
AC:
2162
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 03, 2021- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 28, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: 76% of total chromosomes in ExAC -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 29, 2016- -
Autosomal recessive distal spinal muscular atrophy 1 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Charcot-Marie-Tooth disease Benign:1
Benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Autosomal recessive distal spinal muscular atrophy 1;C4015349:Charcot-Marie-Tooth disease axonal type 2S Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Charcot-Marie-Tooth disease axonal type 2S Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabAug 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
Cadd
Benign
12
Dann
Benign
0.79
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1249463; hg19: chr11-68671477; COSMIC: COSV54826298; COSMIC: COSV54826298; API